Plenary Session

Plenary



The seven plenary sessions are the core of the ISSCR Annual Meeting, featuring leaders in stem cell and related fields. The plenary sessions showcase speakers who will inspire and invigorate all attendees with cutting-edge research and thought. Award lectures and other featured lectures are also presented in the plenary sessions.

Plenary VII: Moving to the Clinic: Gene and Stem Cell Therapies

6/23/2018
16:00 - 18:15

Presentations:

Michael Laflamme

Toronto General Hospital Research Institute, University Health Network, ON, Canada

Dr. Michael Laflamme is the Robert McEwen Chair in Cardiac Regenerative Medicine at University Health Network, and his research program is focused on developing cardiac cell therapies based on pluripotent stem cells. He has been the recipient of honors including the Society for Cardiovascular Pathology Young Investigator Award, the Perkins Coie Award for Discovery and the American Society of Gene & Cell Therapy Outstanding New Investigator Award. Dr. Laflamme also practices diagnostic cardiovascular pathology.

Presentation(s):

Send Email for Michael Laflamme

Stanley R. Riddell

University of Washington, WA, United States

Dr. Stanley Riddell is a Member in the Program in Immunology and Director of the Integrated Immunotherapy Research Center at the Fred Hutchinson Cancer Research Center. His research focuses on understanding T cell immunity to pathogens and tumors, and on the development and clinical application of adoptive T cell therapy for cancer using genetic modification of T cells to confer tumor specificity and overcome barriers to tumor eradication.

Presentation(s):

Send Email for Stanley Riddell

Send Email for Shivani Srivastava

Send Email for Alex Salter

Send Email for Margot Pont

Send Email for Josh Veatch

Send Email for Isabel Leung

Send Email for Simon Fraessle

Katherine High

Spark Therapeutics, PA, United States

John McNeish Memorial Lecture

Dr. Katherine High is currently President and Head of R&D at Spark Therapeutics, a publicly traded biotech company focused on discovering, developing, and delivering life-altering transformation for those patients and families affected by genetic disease. Prior to joining Spark, Dr. High was the William Bennett Professor of Pediatrics at the Perelman School of Medicine of the University of Pennsylvania, and an Investigator of the Howard Hughes Medical Institute. She is a past president of the American Society of Gene and Cell Therapy.

Presentation(s):

Send Email for Katherine High

Jennifer Doudna

University of California, Berkeley and HHMI, CA, United States

As a professor of Chemistry and Molecular and Cell Biology at UC Berkeley, Doudna’s research focuses on RNA-mediated gene regulation and genome editing. Doudna is an Investigator with the Howard Hughes Medical Institute and a recipient of multiple research awards. She is the co-author with Sam Sternberg of “A Crack in Creation”, a personal account of the advent of CRISPR gene editing technology and the societal and ethical implications of genome editing.

Presentation(s):

Send Email for Jennifer Doudna


Assets

Plenary VII: Moving to the Clinic: Gene and Stem Cell Therapies



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Plenary VII: Moving to the Clinic: Gene and Stem Cell Therapies